Larry W Tsai MD
Critical Care Medicine, Pleural Disease
Instructor in Medicine, Brigham and Women's Hospital
Join to View Full Profile
75 Francis Street Pbb Clinics 3Brigham And Women's Hospital Pulmonary DivisionBoston, MA 02115
Phone+1 617-732-5500
Dr. Tsai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2003
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 2000
Harvard Medical SchoolClass of 1997
Certifications & Licensure
CA State Medical License 2000 - 2025
MA State Medical License 1999 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study Start of enrollment: 2018 Mar 20
Publications & Presentations
PubMed
- 21 citationsPrognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial.Jennifer Tom, Min Bao, Larry W. Tsai, Aditi Qamra, David Summers
Critical Care Medicine. 2021-10-12 - 9 citationsMass Balance and Drug Interaction Potential of Intravenous Eravacycline Administered to Healthy Subjects.Joseph V. Newman, Jian Zhou, Sergey Izmailyan, Larry W. Tsai
Antimicrobial Agents and Chemotherapy. 2019-02-26 - 25 citationsRandomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline.Joseph V. Newman, Jian Zhou, Sergey Izmailyan, Larry Tsai
Antimicrobial Agents and Chemotherapy. 2018-10-24
Journal Articles
- Tocilizumab in Hospitalized Patients with Severe Covid-19 PneumoniaIvan O Rosas, Ronaldo C Go, Ivor S Douglas, Larry Tsai, Atul Malhotra, The New England Journal of Medicine
Press Mentions
Tetraphase Pharmaceuticals Announces Corporate Reorganization Aimed at Maximizing XERAVA™ (Eravacycline) Commercial OpportunityJune 12th, 2019
Tetraphase Pharmaceuticals Announces New XERAVA™ (Eravacycline) Data at the 39June 10th, 2019
Weekly Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Ratings on Dec 15, 2018December 15th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
